1144O Osteopontin (OPN) predicts the efficacy of anti-angiogenic therapy with multikinase inhibitors (MKIs) in advanced neuroendocrine tumors (NETs): Underlying molecular mechanism... von Lens-Pardo, A., Carretero-Puche, C., Antón Pascual, B., Capdevila Castillon, J., Benavent Viñuales, M., Jimenez Fonseca, P., Grande, E., Perna, C., Caminoa, A., Rubio-Cuesta, B., Sarmentero, J., Gil-Calderón, B., Llamas, P., Soldevilla, B., Garcia-Carbonero, R.

Volltext

1143O Refining molecular classification of neuroendocrine tumors from diverse origins using multi-omic integration models: Unveiling novel neuroendocrine subtypes and their clinica... von Carretero-Puche, C., Antón Pascual, B., Lens-Pardo, A., Benavent Viñuales, M., Gomez-Izquierdo, L., Jimenez Fonseca, P., Teijo, A., Rodríguez, Y., Rubio-Cuesta, B., Lamas-Paz, A., Gomez-Lopez, G., Soldevilla, B., Garcia-Carbonero, R.

Volltext

1142O Multivariable analysis of streptozotocin plus 5-fluorouracil and everolimus sequences in advanced pancreatic neuroendocrine tumor patients: The SEQTOR trial (GETNE-1206) von Capdevila Castillon, J., Tafuto, S., Krogh, M., Teule, A., Garcia-Carbonero, R., Klumpen, H.J., Cremer, B., Sevilla, I., Eriksson, B.K., Mitkina Tabaksblat, E., Metges, J-P., Reed, N.S., Schrader, J., Bozzarelli, S., Knigge, U., Jimenez-Fonseca, P., Benavent Viñuales, M., Venerito, M., Navarro, V., Salazar Soler, R.

Volltext

723O Cabozantinib plus atezolizumab in advanced and progressive neoplasms of the endocrine system: A multi-cohort basket phase II trial (CABATEN/GETNE-T1914) von Castillon, J. Capdevila, Molina-Cerrillo, J., Viñuales, M. Benavent, Garcia-Carbonero, R., Teule, A., Custodio, A., Jimenez-Fonseca, P., López, C., Hierro, C., Carmona-Bayonas, A., Martínez-Trufero, J., Llanos, M., Sevilla, I., Hernando, J., Alonso-Gordoa, T., Jimenez, I. Gallego, Gallego, J., Pascual, B. Antón, Grande, E.

Volltext

1098O Nivolumab plus platinum-doublet chemotherapy as first-line therapy in unresectable, locally advanced or metastatic G3 neuroendocrine Neoplasms (NENs) of the gastroenteropancr... von Riesco-Martinez, M.C., Capdevila, J., Alonso, V., Jimenez-Fonseca, P., Teule, A., Grande, E., Sevilla, I., Benavent Viñuales, M., Alonso-Gordoa, T., Custodio, A., Hernando, J., Polo, E., Castillo Trujillo, O.A., Garcia-Carbonero, R.

Volltext

1099MO Durvalumab plus tremelimumab influence on response to subsequent treatments in patients with neuroendocrine neoplasms (NENs) of gastroenteropancreatic and lung origins: Resu... von Hernando, J., Manzano, J.L., Teule, A., López, C., Garcia-Carbonero, R., Benavent Viñuales, M., Custodio, A., Cubillo, A., Alonso, V., Alonso-Gordoa, T., Carmona-Bayonas, A., Crespo, G., Blanco, M., Jimenez-Fonseca, P., Viudez, A., La Casta, A., Sevilla, I., Llanos, M., Segura, Á., Capdevila, J.

Volltext

575TiP Cabozantinib plus atezolizumab in advanced and progressive neoplasms of the endocrine system: A multicohort phase II trial (CABATEN trial / GETNE-T1914) von Grande, E., Garcia-Carbonero, R., Teule, A., Benavent Viñuales, M., Jimenez-Fonseca, P., Molina-Cerrillo, J., López, C., Custodio, A., Hierro, C., Gallego, J., Alonso, V., Carmona-Bayonas, A., Llanos, M., Sevilla, I., Hernando, J., Lista, F., Antón Pascual, B., Ruffinelli, J.C., Gallego Jiménez, I., Capdevila, J.

Volltext

1107P Durvalumab plus tremelimumab in patients with grade 3 neuroendocrine neoplasms of gastroenteropancreatic origin: Updated results from the multicenter phase II DUNE trial (GET... von Capdevila, J., Landolfi, S., Hernando, J., Teule, A., Garcia-Carbonero, R., Custodio, A., Cubillo, A., Alonso-Gordoa, T., Carmona-Bayonas, A., Crespo, G., Blanco, M., Viudez, A., La Casta, A., Sevilla, I., Segura, Á., López, C., Benavent Viñuales, M., Nuciforo, P., Manzano, J.L.

Volltext

103P PET-CT in localized breast cancer: Does it impact on the therapeutic decision? von Rodriguez, P. Macias, Perez, R. Buezas, Cejuela, M., Gonzalez, A. Falcon, Torralvo, A. Gil, Viñuales, M. Benavent, Alvarez, R.M., Cases, C., Borrego, M. Ruiz, Bofill, F.J. Salvador

Volltext